April 24, 2024

Infectious Disease in-Vitro Diagnostics Market Size to Garner USD 28.62 Billion by 2032

The global Infectious disease in-vitro diagnostics market size was estimated to be around US$ 84.63 billion in 2022. It is projected to reach US$ 28.62 billion by 2032, indicating a CAGR of -10.31% from 2023 to 2032.

Infectious Disease In-Vitro Diagnostics Market Size 2023 To 2032

Key Takeaways:

  • By Products, the reagents segment dominated the market in 2022.
  • By Technology, the molecular diagnostics segment held a dominating share in 2022.
  • By Technology, the immunoassay segment is predicted to grow quickly between 2023 and 2032.
  • By Test Location, the central laboratories segment led the market with the largest market share of 56% in 2022.
  • North America dominates the global market with the highest market share of 56% in 2022.
  • Europe region is expected to expand at the fastest CAGR between 2023 and 2032.

The market research report on the Infectious disease in-vitro diagnostics market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Infectious disease in-vitro diagnostics products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3261

Report Scope of the Infectious Disease in-Vitro Diagnostics Market:

Report Coverage Details
Market Size in 2023 USD 76.24 Billion
Market Size by 2032 USD 28.62 Billion
Growth Rate from 2023 to 2032 CAGR of -10.31%
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Product, By Technology, and By Test Location
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Medical Imaging Displays Market Size to Garner USD 9.14 Billion by 2032

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global Infectious disease in-vitro diagnostics market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Infectious disease in-vitro diagnostics market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Infectious disease in-vitro diagnostics products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the Infectious disease in-vitro diagnostics market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on Infectious disease in-vitro diagnostics market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Infectious disease in-vitro diagnostics market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Key Market Players:

A few of the prominent players of the global infectious disease in-vitro diagnostics market include:

  • QIAGEN
  • BD
  • BioMérieux SA
  • F. Hoffmann-La Roche, Ltd.
  • Hologic, Inc. (Gen Probe)
  • Abbott
  • Quidel Corporation
  • Siemens Healthineers AG
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • OraSure Technologies, Inc.

Segments Covered in the Report:

By Product

  • Instruments
  • Reagents

By Technology

  • Immunoassay
  • Molecular Diagnostics
  • Microbiology

By Test Location

  • Point of Care
  • Central Laboratories

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Infectious Disease in-Vitro Diagnostics Market 

5.1. COVID-19 Landscape: Infectious Disease in-Vitro Diagnostics Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Infectious Disease in-Vitro Diagnostics Market, By Product

8.1. Infectious Disease in-Vitro Diagnostics Market, by Product, 2023-2032

8.1.1 Instruments

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Reagents

8.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 9. Global Infectious Disease in-Vitro Diagnostics Market, By Technology

9.1. Infectious Disease in-Vitro Diagnostics Market, by Technology, 2023-2032

9.1.1. Immunoassay

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Molecular Diagnostics

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Microbiology

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. Global Infectious Disease in-Vitro Diagnostics Market, By Test Location 

10.1. Infectious Disease in-Vitro Diagnostics Market, by Test Location, 2023-2032

10.1.1. Point of Care

10.1.1.1. Market Revenue and Forecast (2020-2032)

10.1.2. Central Laboratories

10.1.2.1. Market Revenue and Forecast (2020-2032)

Chapter 11. Global Infectious Disease in-Vitro Diagnostics Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.1.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.1.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.2.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.2.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.3.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.3.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.6.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.6.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product (2020-2032)

11.4.7.2. Market Revenue and Forecast, by Technology (2020-2032)

11.4.7.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.4.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.4.3. Market Revenue and Forecast, by Test Location (2020-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product (2020-2032)

11.5.5.2. Market Revenue and Forecast, by Technology (2020-2032)

11.5.5.3. Market Revenue and Forecast, by Test Location (2020-2032)

Chapter 12. Company Profiles

12.1. QIAGEN

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. BD

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BioMérieux SA

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. F. Hoffmann-La Roche, Ltd.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Hologic, Inc. (Gen Probe)

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Abbott

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Quidel Corporation

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Siemens Healthineers AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Bio-Rad Laboratories, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Danaher Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *